Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Dupuytren's Disease: later-stage trial registry
1 of 5 indexed Dupuytren's Disease trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Dupuytren's Disease: 5 US clinical trials tracked, 1 recruiting.
Dupuytren's Disease is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Endo Pharmaceuticals, running 1 of these trials.
Enrollment posture brief
Registry condition dupuytrens-disease
OPEN 1 | RECR 20% | LATE 3 | EARLY 1 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)
Dupuytren's Disease lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Dupuytren's Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Dupuytren's Disease is recruiting below its size-band peers.
1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Dupuytren's Disease research.
Endo Pharmaceuticals accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Most Dupuytren's Disease trials plan to enrol fewer than 100 people.
Median target enrolment is 50 among the 5 trials that report a genuine target (sentinel values excluded). 5 of those (100%) plan for fewer than 100 participants.
-
Dupuytren's Disease research is mostly interventional.
4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Post-contracture Release Radiation for Dupuytren's Disease
University of Minnesota
NCT04122313
Effectiveness of Splinting After Collagenase Injection
Foundation for Orthopaedic Research and Education
NCT04874870
Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules
Endo Pharmaceuticals
NCT02193828
Collagenase in the Treatment of Dupuytrens Disease
Stony Brook University
NCT00260429
MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex
Hospital for Special Surgery, New York
NCT01450397
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 2 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Dupuytren's Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Dupuytren's Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Dupuytren's Disease page
5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Dupuytren's Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Endo Pharmaceuticals sponsors the most Dupuytren's Disease trials on record, review their full trial history before evaluating a specific study. See Endo Pharmaceuticals's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Dupuytren's Disease condition card totals 5 registered trials; most-linked intervention Collagenase clostridium histolyticum; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.